Swiss pharmaceutical giant Novartis says it is watching "very carefully" how the reciprocal tariff policy proposed by the ...
Kepler Capital analyst David Evans maintained a Buy rating on Novartis AG (NOVN – Research Report) on March 13 and set a price target of ...
Sportcal on MSN2d
Novartis in as first NFL pharmaceutical sponsorAmerican football’s elite National Football League (NFL) has brought in US medicine company Novartis as the property's first-ever pharmaceutical partner. Novartis, granted exclusivity in the corporate ...
MedPage Today on MSN3d
Approved Sickle Cell Drug Fails to Beat Placebo in TrialCrizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.
A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...
Novartis has teamed up with the NFL in a multi-year partnership, marking the first such collaboration between the football ...
The NFL have signed its first-ever pharmaceutical partner in a multi-year deal with Novartis to focus on the NFL’s health ...
The National Football League has signed its first-ever pharmaceutical partner in a multi-year deal with Switzerland-based ...
Legend Biotech is building a new $150 million manufacturing plant, with its partner Johnson & Johnson, with the goal of ...
The NFL has inked a multi-year deal with pharmaceutical giant Novartis, marking its first such partnership. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback